Results 201 to 210 of about 763,675 (267)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Letter to the Editor: Response to outcomes of "right <i>vs</i> left kidney". [PDF]

World J Transplant
Khan T, Iqbal Q, Hassan M, Shakeel S, Khan N, Asnath L.   +5 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinoma. [PDF]

Front Immunol
Monaco F, Tran DT, Sandmaier BM, Tykodi SS.   +3 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Long-term outcomes of lung transplantation in the elderly: an analysis using the UNOS database. [PDF]

J Thorac Dis
Shtraichman O, Meyer JS, Zur A, Leor G, Aravot D, Peysakhovich Y, Shostak Y, Kramer MR, Barac YD.   +8 more
europepmc   +1 more source

Optimising transfusion practices in preterm neonates using gestational age and birth weight-based prediction model: a retrospective cohort study from India. [PDF]

BMJ Paediatr Open
Krishnakumar M, Ajith A, Gutjahr G, Biju S, Shenoy V, A D, Bendapudi P.   +6 more
europepmc   +1 more source

From laparoscopy to robotics in living donor hepatectomy: a systematic review and meta-analysis of comparative outcomes. [PDF]

J Robot Surg
Al Sayed M, Albashier M, Altabbaa H, Omar Saleh A, Hadhoud AM, Hussein MA, Aljarrah AY, Abdelrazek MM, Bakhiet M.   +8 more
europepmc   +1 more source

Association of PIRCHE scores and allograft injury in kidney transplant recipients. [PDF]

Front Immunol
Molnar MZ, Holdaway KJ, Raghavan D, Marineci S, Oygen S, Toth F, Fornadi K.   +6 more
europepmc   +1 more source